Cargando…
Insulin-like peptide 3 (INSL3) in congenital hypogonadotrophic hypogonadism (CHH) in boys with delayed puberty and adult men
BACKGROUND: Delayed puberty in males is almost invariably associated with constitutional delay of growth and puberty (CDGP) or congenital hypogonadotrophic hypogonadism (CHH). Establishing the cause at presentation is challenging, with “red flag” features of CHH commonly overlooked. Thus, several ma...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745113/ https://www.ncbi.nlm.nih.gov/pubmed/36523592 http://dx.doi.org/10.3389/fendo.2022.1076984 |
_version_ | 1784849073971396608 |
---|---|
author | Abbara, Ali Koysombat, Kanyada Phylactou, Maria Eng, Pei Chia Clarke, Sophie Comninos, Alexander N. Yang, Lisa Izzi-Engbeaya, Chioma Hanassab, Simon Smith, Neil Jayasena, Channa N. Xu, Cheng Quinton, Richard Pitteloud, Nelly Binder, Gerhard Anand-Ivell, Ravinder Ivell, Richard Dhillo, Waljit S. |
author_facet | Abbara, Ali Koysombat, Kanyada Phylactou, Maria Eng, Pei Chia Clarke, Sophie Comninos, Alexander N. Yang, Lisa Izzi-Engbeaya, Chioma Hanassab, Simon Smith, Neil Jayasena, Channa N. Xu, Cheng Quinton, Richard Pitteloud, Nelly Binder, Gerhard Anand-Ivell, Ravinder Ivell, Richard Dhillo, Waljit S. |
author_sort | Abbara, Ali |
collection | PubMed |
description | BACKGROUND: Delayed puberty in males is almost invariably associated with constitutional delay of growth and puberty (CDGP) or congenital hypogonadotrophic hypogonadism (CHH). Establishing the cause at presentation is challenging, with “red flag” features of CHH commonly overlooked. Thus, several markers have been evaluated in both the basal state or after stimulation e.g. with gonadotrophin releasing hormone agonist (GnRHa). Insulin-like peptide 3 (INSL3) is a constitutive secretory product of Leydig cells and thus a possible candidate marker, but there have been limited data examining its role in distinguishing CDGP from CHH. In this manuscript, we assess INSL3 and inhibin B (INB) in two cohorts: 1. Adolescent boys with delayed puberty due to CDGP or CHH and 2. Adult men, both eugonadal and having CHH. MATERIALS AND METHODS: Retrospective cohort studies of 60 boys with CDGP or CHH, as well as 44 adult men who were either eugonadal or had CHH, in whom INSL3, INB, testosterone and gonadotrophins were measured. Cohort 1: Boys with delayed puberty aged 13-17 years (51 with CDGP and 9 with CHH) who had GnRHa stimulation (subcutaneous triptorelin 100mcg), previously reported with respect to INB. Cohort 2: Adult cohort of 44 men (22 eugonadal men and 22 men with CHH), previously reported with respect to gonadotrophin responses to kisspeptin-54. RESULTS: Median INSL3 was higher in boys with CDGP than CHH (0.35 vs 0.15 ng/ml; p=0.0002). Similarly, in adult men, median INSL3 was higher in eugonadal men than CHH (1.08 vs 0.05 ng/ml; p<0.0001). However, INSL3 more accurately differentiated CHH in adult men than in boys with delayed puberty (auROC with 95% CI in adult men: 100%, 100-100%; boys with delayed puberty: 86.7%, 77.7-95.7%). Median INB was higher in boys with CDGP than CHH (182 vs 59 pg/ml; p<0.0001). Likewise, in adult men, median INB was higher in eugonadal men than CHH (170 vs 36.5 pg/ml; p<0.0001). INB performed better than INSL3 in differentiating CHH in boys with delayed puberty (auROC 98.5%, 95.9-100%), than in adult men (auROC 93.9%, 87.2-100%). CONCLUSION: INSL3 better identifies CHH in adult men, whereas INB better identifies CHH in boys with delayed puberty. |
format | Online Article Text |
id | pubmed-9745113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97451132022-12-14 Insulin-like peptide 3 (INSL3) in congenital hypogonadotrophic hypogonadism (CHH) in boys with delayed puberty and adult men Abbara, Ali Koysombat, Kanyada Phylactou, Maria Eng, Pei Chia Clarke, Sophie Comninos, Alexander N. Yang, Lisa Izzi-Engbeaya, Chioma Hanassab, Simon Smith, Neil Jayasena, Channa N. Xu, Cheng Quinton, Richard Pitteloud, Nelly Binder, Gerhard Anand-Ivell, Ravinder Ivell, Richard Dhillo, Waljit S. Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Delayed puberty in males is almost invariably associated with constitutional delay of growth and puberty (CDGP) or congenital hypogonadotrophic hypogonadism (CHH). Establishing the cause at presentation is challenging, with “red flag” features of CHH commonly overlooked. Thus, several markers have been evaluated in both the basal state or after stimulation e.g. with gonadotrophin releasing hormone agonist (GnRHa). Insulin-like peptide 3 (INSL3) is a constitutive secretory product of Leydig cells and thus a possible candidate marker, but there have been limited data examining its role in distinguishing CDGP from CHH. In this manuscript, we assess INSL3 and inhibin B (INB) in two cohorts: 1. Adolescent boys with delayed puberty due to CDGP or CHH and 2. Adult men, both eugonadal and having CHH. MATERIALS AND METHODS: Retrospective cohort studies of 60 boys with CDGP or CHH, as well as 44 adult men who were either eugonadal or had CHH, in whom INSL3, INB, testosterone and gonadotrophins were measured. Cohort 1: Boys with delayed puberty aged 13-17 years (51 with CDGP and 9 with CHH) who had GnRHa stimulation (subcutaneous triptorelin 100mcg), previously reported with respect to INB. Cohort 2: Adult cohort of 44 men (22 eugonadal men and 22 men with CHH), previously reported with respect to gonadotrophin responses to kisspeptin-54. RESULTS: Median INSL3 was higher in boys with CDGP than CHH (0.35 vs 0.15 ng/ml; p=0.0002). Similarly, in adult men, median INSL3 was higher in eugonadal men than CHH (1.08 vs 0.05 ng/ml; p<0.0001). However, INSL3 more accurately differentiated CHH in adult men than in boys with delayed puberty (auROC with 95% CI in adult men: 100%, 100-100%; boys with delayed puberty: 86.7%, 77.7-95.7%). Median INB was higher in boys with CDGP than CHH (182 vs 59 pg/ml; p<0.0001). Likewise, in adult men, median INB was higher in eugonadal men than CHH (170 vs 36.5 pg/ml; p<0.0001). INB performed better than INSL3 in differentiating CHH in boys with delayed puberty (auROC 98.5%, 95.9-100%), than in adult men (auROC 93.9%, 87.2-100%). CONCLUSION: INSL3 better identifies CHH in adult men, whereas INB better identifies CHH in boys with delayed puberty. Frontiers Media S.A. 2022-11-29 /pmc/articles/PMC9745113/ /pubmed/36523592 http://dx.doi.org/10.3389/fendo.2022.1076984 Text en Copyright © 2022 Abbara, Koysombat, Phylactou, Eng, Clarke, Comninos, Yang, Izzi-Engbeaya, Hanassab, Smith, Jayasena, Xu, Quinton, Pitteloud, Binder, Anand-Ivell, Ivell and Dhillo https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Abbara, Ali Koysombat, Kanyada Phylactou, Maria Eng, Pei Chia Clarke, Sophie Comninos, Alexander N. Yang, Lisa Izzi-Engbeaya, Chioma Hanassab, Simon Smith, Neil Jayasena, Channa N. Xu, Cheng Quinton, Richard Pitteloud, Nelly Binder, Gerhard Anand-Ivell, Ravinder Ivell, Richard Dhillo, Waljit S. Insulin-like peptide 3 (INSL3) in congenital hypogonadotrophic hypogonadism (CHH) in boys with delayed puberty and adult men |
title | Insulin-like peptide 3 (INSL3) in congenital hypogonadotrophic hypogonadism (CHH) in boys with delayed puberty and adult men |
title_full | Insulin-like peptide 3 (INSL3) in congenital hypogonadotrophic hypogonadism (CHH) in boys with delayed puberty and adult men |
title_fullStr | Insulin-like peptide 3 (INSL3) in congenital hypogonadotrophic hypogonadism (CHH) in boys with delayed puberty and adult men |
title_full_unstemmed | Insulin-like peptide 3 (INSL3) in congenital hypogonadotrophic hypogonadism (CHH) in boys with delayed puberty and adult men |
title_short | Insulin-like peptide 3 (INSL3) in congenital hypogonadotrophic hypogonadism (CHH) in boys with delayed puberty and adult men |
title_sort | insulin-like peptide 3 (insl3) in congenital hypogonadotrophic hypogonadism (chh) in boys with delayed puberty and adult men |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745113/ https://www.ncbi.nlm.nih.gov/pubmed/36523592 http://dx.doi.org/10.3389/fendo.2022.1076984 |
work_keys_str_mv | AT abbaraali insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen AT koysombatkanyada insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen AT phylactoumaria insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen AT engpeichia insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen AT clarkesophie insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen AT comninosalexandern insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen AT yanglisa insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen AT izziengbeayachioma insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen AT hanassabsimon insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen AT smithneil insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen AT jayasenachannan insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen AT xucheng insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen AT quintonrichard insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen AT pitteloudnelly insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen AT bindergerhard insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen AT anandivellravinder insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen AT ivellrichard insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen AT dhillowaljits insulinlikepeptide3insl3incongenitalhypogonadotrophichypogonadismchhinboyswithdelayedpubertyandadultmen |